ACADIAN ASSET MANAGEMENT LLC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 25 filers reported holding UNUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$757,000
+370.2%
323,036
-7.1%
0.00%
+200.0%
Q2 2020$161,000
+215.7%
347,847
+183.4%
0.00%
Q1 2020$51,000
-42.0%
122,7340.0%0.00%
Q4 2019$88,000
+29.4%
122,734
+161.2%
0.00%
Q3 2019$68,000
-20.0%
46,981
+44.1%
0.00%
Q2 2019$85,000
+39.3%
32,601
+134.8%
0.00%
Q1 2019$61,00013,8840.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$37,347,00028.23%
Novo Holdings A/S 665,181$31,669,0003.97%
New Leaf Venture Partners, L.L.C. 550,000$6,111,0003.30%
SECTORAL ASSET MANAGEMENT INC 1,081,545$12,016,0001.32%
SABBY MANAGEMENT, LLC 1,106,445$12,292,0000.73%
Monashee Investment Management LLC 175,000$1,944,0000.54%
DC Investments Management, LLC 35,524$395,0000.26%
Athanor Capital, LP 22,300$248,0000.12%
PLATINUM INVESTMENT MANAGEMENT LTD 225,000$2,499,0000.07%
Schonfeld Strategic Advisors LLC 73,000$811,0000.06%
View complete list of UNUM THERAPEUTICS INC shareholders